Inmune Bio, Inc.
SEC CIK 1711754 · INMB · last insider filing 2025-12-02
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Allen Marcia | Director | filed 2020 - 2025 |
| Moss David J | Director · Chief Financial Officer | filed 2019 - 2025 |
| Juda Scott | Director | filed 2019 - 2025 |
| Schroeder Timothy j | Director | filed 2019 - 2025 |
| Ganjei James Kelly | Director | filed 2019 - 2025 |
| Tesi Raymond Joseph | Director · President and CEO | filed 2019 - 2024 |
| Baracchini Edgardo Jr | Director | filed 2019 - 2024 |
| Szymkowski David Edmund | Director | filed 2019 - 2019 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Lowdell Mark William | Chief Scientific Officer | filed 2019 - 2025 |
| Ellspermann Cory Randall | Interim CFO | filed 2025 - 2025 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.